Skip to main content
Livermore
Livermore
ZHEN

Greenleaf Trust

SEC CIK
0001162170
Latest filing
Jul 21, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Greenleaf Trust, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of ALNY by Greenleaf Trust, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−2,733−100.0%Sold outHolders
Q4 20252,733$1.09M<0.1%−2−0.1%ReducedHolders
Q3 20252,735$1.25M<0.1%+5+0.2%AddedHolders
Q2 20252,730$890.2K<0.1%−20−0.7%ReducedHolders
Q1 20252,750$742.6K<0.1%+28+1.0%AddedHolders
Q4 20242,722$640.5K<0.1%+4+0.1%AddedHolders
Q3 20242,718$747.5K<0.1%−2−0.1%ReducedHolders
Q2 20242,720$661.0K<0.1%−143−5.0%ReducedHolders
Q1 20242,863$427.9K<0.1%−75−2.6%ReducedHolders
Q4 20232,938$562.4K<0.1%+405+16.0%AddedHolders
Q3 20232,533$448.6K<0.1%−90−3.4%ReducedHolders
Q2 20232,623$498.2K<0.1%−137−5.0%ReducedHolders
Q1 20232,760$552.9K<0.1%+61+2.3%AddedHolders
Q4 20222,699$641.0K<0.1%+24+0.9%AddedHolders
Q3 20222,675$535.0K<0.1%+118+4.6%AddedHolders
Q2 20222,557$373.0K<0.1%+181+7.6%AddedHolders
Q1 20222,376$388.0K<0.1%−811−25.4%ReducedHolders
Q4 20213,187$540.0K<0.1%00.0%UnchangedHolders
Q3 20213,187$602.0K<0.1%00.0%UnchangedHolders
Q2 20213,187$540.0K<0.1%+40+1.3%AddedHolders
Q1 20213,147$444.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.